TY - CHAP T1 - Zolpidem BT - Drugs and Lactation Database (LactMed) Y1 - 2006/// PY - 2018/7/13/pubmed PY - 2018/7/13/medline PY - 2018/7/13/entrez KW - zolpidem KW - Zolpidemum KW - Lorex KW - Zolpidemum [Latin] KW - 82626-48-0 KW - Zolpidem [INN:BAN] KW - UNII-7K383OQI23 KW - DEA No. 2783 KW - 7K383OQI23 KW - SL800750 KW - SL 800750 KW - SL 80-0750 KW - N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide KW - Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)- N2 - Little information is available on the use of zaleplon during breastfeeding. Some expert opinion considers zaleplon to be not recommended during breastfeeding.[1,2] Because of the low levels of zolpidem in breastmilk and its short half-life, amounts ingested by the infant are small and would not be expected to cause any adverse effects in older breastfed infants. Monitor infants for excess sedation, hypotonia, and respiratory depression. PB - National Library of Medicine (US) CY - Bethesda (MD) UR - https://www.unboundmedicine.com/prime/citation/30000324/Drugs_and_Lactation_Database_(LactMed):_Zolpidem L2 - https://www.ncbi.nlm.nih.gov/books/NBK501265 DB - PRIME DP - Unbound Medicine ER -